PL3274340T3 - Inhibitory polimerazy wirusa zapalenia wątroby typu C - Google Patents
Inhibitory polimerazy wirusa zapalenia wątroby typu CInfo
- Publication number
- PL3274340T3 PL3274340T3 PL16717211T PL16717211T PL3274340T3 PL 3274340 T3 PL3274340 T3 PL 3274340T3 PL 16717211 T PL16717211 T PL 16717211T PL 16717211 T PL16717211 T PL 16717211T PL 3274340 T3 PL3274340 T3 PL 3274340T3
- Authority
- PL
- Poland
- Prior art keywords
- hepatitis
- inhibitors
- virus polymerase
- polymerase
- virus
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/77—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D307/78—Benzo [b] furans; Hydrogenated benzo [b] furans
- C07D307/82—Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C07D307/84—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Furan Compounds (AREA)
- Saccharide Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Steroid Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562136857P | 2015-03-23 | 2015-03-23 | |
| PCT/US2016/023664 WO2016154241A1 (en) | 2015-03-23 | 2016-03-23 | Inhibitors of hepatitis c virus polymerase |
| EP16717211.3A EP3274340B1 (en) | 2015-03-23 | 2016-03-23 | Inhibitors of hepatitis c virus polymerase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3274340T3 true PL3274340T3 (pl) | 2020-01-31 |
Family
ID=55759915
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL16717211T PL3274340T3 (pl) | 2015-03-23 | 2016-03-23 | Inhibitory polimerazy wirusa zapalenia wątroby typu C |
Country Status (19)
| Country | Link |
|---|---|
| US (2) | US10464914B2 (pl) |
| EP (1) | EP3274340B1 (pl) |
| JP (1) | JP6741747B2 (pl) |
| KR (1) | KR20170137113A (pl) |
| CN (1) | CN107567442B (pl) |
| AU (1) | AU2016235246B2 (pl) |
| CA (1) | CA2979555C (pl) |
| DK (1) | DK3274340T3 (pl) |
| EA (1) | EA033622B1 (pl) |
| ES (1) | ES2748974T3 (pl) |
| HK (2) | HK1243703A1 (pl) |
| IL (1) | IL254243B (pl) |
| MX (1) | MX2017012238A (pl) |
| NZ (1) | NZ735093A (pl) |
| PH (1) | PH12017501687A1 (pl) |
| PL (1) | PL3274340T3 (pl) |
| SG (1) | SG11201707527YA (pl) |
| TW (1) | TWI731854B (pl) |
| WO (1) | WO2016154241A1 (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI731854B (zh) * | 2015-03-23 | 2021-07-01 | 美商共結晶製藥公司 | Ｃ型肝炎病毒聚合酶之抑制劑 |
| AU2019265740A1 (en) * | 2018-05-09 | 2020-10-29 | Cocrystal Pharma, Inc. | Combination therapy for treatment of HCV |
| CN112745216A (zh) * | 2019-10-30 | 2021-05-04 | 常州锐博生物科技有限公司 | 一种4-溴甲基苯甲酸甲酯及其衍生物的制备方法 |
| CN114181187A (zh) * | 2021-11-24 | 2022-03-15 | 上海应用技术大学 | 一种4-甲磺酰胺基丁酰胺化合物的制备方法 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1184425A (zh) | 1995-03-20 | 1998-06-10 | 伊莱利利公司 | 5－取代－3－(1,2,3,6－四氢吡啶－4－基)－和3－(哌啶－4－基)－1h－吲哚:新型5－ht1f激动剂 |
| US6350458B1 (en) | 1998-02-10 | 2002-02-26 | Generex Pharmaceuticals Incorporated | Mixed micellar drug deliver system and method of preparation |
| AP1753A (en) | 2001-06-11 | 2007-07-18 | Shire Biochem Inc | Thiophene derivatives as antiviral agents for flavvivirus infection |
| EP1395571A1 (en) | 2001-06-11 | 2004-03-10 | Shire Biochem Inc. | Compounds and methods for the treatment or prevention of flavivirus infections |
| US6936629B2 (en) | 2001-12-21 | 2005-08-30 | Virochem Pharma Inc. | Compounds and methods for the treatment or prevention of flavivirus infections |
| WO2004041201A2 (en) * | 2002-11-01 | 2004-05-21 | Viropharma Incorporated | Benzofuran compounds, compositions and methods for treatment and prophylaxis of hepatitis c viral infections and associated diseases |
| KR101058696B1 (ko) | 2002-12-10 | 2011-08-22 | 바이로켐 파마 인코포레이티드 | 후라비바이러스 감염의 치료 또는 예방을 위한 화합물과방법 |
| AU2003291885A1 (en) | 2002-12-10 | 2004-06-30 | Virochem Pharma Inc. | Compounds and methods for the treatment or prevention of flavivirus infections |
| US20040192707A1 (en) | 2002-12-10 | 2004-09-30 | Laval Chan Chun Kong | Compounds and methods for the treatment or prevention of Flavivirus infections |
| WO2005113548A1 (en) | 2004-05-20 | 2005-12-01 | Sugen, Inc. | Thiophene heteroaryl amines |
| DE102004061746A1 (de) | 2004-12-22 | 2006-07-06 | Bayer Healthcare Ag | Alkinyl-substituierte Thiophene |
| ES2415742T3 (es) | 2005-05-13 | 2013-07-26 | Vertex Pharmaceuticals (Canada) Incorporated | Compuestos y procedimientos para el tratamiento o prevención de infecciones por flavivirus |
| US20090136448A1 (en) | 2005-12-22 | 2009-05-28 | John Andrew Corfield | Antiviral 2-Carboxy-Thiophene Compounds |
| WO2008017688A1 (en) | 2006-08-11 | 2008-02-14 | Smithkline Beecham Corporation | 2-carboxy thiophene derivatives as anti-viral agents |
| TW200815384A (en) | 2006-08-25 | 2008-04-01 | Viropharma Inc | Combination therapy method for treating hepatitis C virus infection and pharmaceutical compositions for use therein |
| WO2008043791A2 (en) | 2006-10-13 | 2008-04-17 | Smithkline Beecham Corporation | Thiophene derivatives for treating hepatitis c |
| EA201101492A1 (ru) | 2006-11-15 | 2012-09-28 | Вирокем Фарма Инк. | Аналоги тиофена для лечения или предупреждения флавивирусных инфекций |
| WO2008059042A1 (en) | 2006-11-17 | 2008-05-22 | Smithkline Beecham Corporation | 2-carboxy thiophene derivatives as anti viral agents |
| GB0707092D0 (en) | 2007-04-12 | 2007-05-23 | Smithkline Beecham Corp | Compounds |
| GB0712393D0 (en) | 2007-06-26 | 2007-08-01 | Smithkline Beecham Corp | Compounds |
| GB0718435D0 (en) * | 2007-09-21 | 2007-10-31 | Northern Health And Social Car | Wpund care formulation |
| EP2245023B1 (en) | 2008-02-14 | 2011-12-28 | F. Hoffmann-La Roche AG | Heterocyclic antiviral compounds |
| WO2009137500A1 (en) * | 2008-05-05 | 2009-11-12 | Wyeth | 6-substituted benzofuran compounds to treat infection with hepatitis c virus |
| AR080433A1 (es) * | 2010-03-02 | 2012-04-11 | Merck Sharp & Dohme | Derivados de benzofurancarboxamidas utiles para tratar o prevenir infecciones por vhc y composiciones farmaceuticas que los contienen. |
| WO2011106929A1 (en) | 2010-03-02 | 2011-09-09 | Merck Sharp & Dohme Corp. | Inhibitors of hepatitis c virus ns5b polymerase |
| US8324239B2 (en) * | 2010-04-21 | 2012-12-04 | Novartis Ag | Furopyridine compounds and uses thereof |
| TW201221131A (en) * | 2010-11-18 | 2012-06-01 | Glaxo Group Ltd | Compounds |
| US8771665B2 (en) | 2010-12-17 | 2014-07-08 | Cocrystal Discovery, Inc. | Inhibitors of hepatitis C virus polymerase |
| WO2014055142A1 (en) | 2012-06-20 | 2014-04-10 | Cocrystal Discovery, Inc. | Inhibitors of hepatitis c virus polymerase |
| TWI731854B (zh) * | 2015-03-23 | 2021-07-01 | 美商共結晶製藥公司 | Ｃ型肝炎病毒聚合酶之抑制劑 |
-
2016
- 2016-03-21 TW TW105108618A patent/TWI731854B/zh active
- 2016-03-23 AU AU2016235246A patent/AU2016235246B2/en active Active
- 2016-03-23 DK DK16717211.3T patent/DK3274340T3/da active
- 2016-03-23 WO PCT/US2016/023664 patent/WO2016154241A1/en active Application Filing
- 2016-03-23 KR KR1020177030184A patent/KR20170137113A/ko active IP Right Grant
- 2016-03-23 JP JP2018501147A patent/JP6741747B2/ja active Active
- 2016-03-23 CN CN201680017709.XA patent/CN107567442B/zh active Active
- 2016-03-23 SG SG11201707527YA patent/SG11201707527YA/en unknown
- 2016-03-23 EP EP16717211.3A patent/EP3274340B1/en active Active
- 2016-03-23 US US15/556,653 patent/US10464914B2/en active Active
- 2016-03-23 MX MX2017012238A patent/MX2017012238A/es unknown
- 2016-03-23 ES ES16717211T patent/ES2748974T3/es active Active
- 2016-03-23 NZ NZ735093A patent/NZ735093A/en unknown
- 2016-03-23 EA EA201792094A patent/EA033622B1/ru not_active IP Right Cessation
- 2016-03-23 PL PL16717211T patent/PL3274340T3/pl unknown
- 2016-03-23 CA CA2979555A patent/CA2979555C/en active Active
-
2017
- 2017-08-31 IL IL254243A patent/IL254243B/en active IP Right Grant
- 2017-09-14 PH PH12017501687A patent/PH12017501687A1/en unknown
-
2018
- 2018-03-02 HK HK18103065.4A patent/HK1243703A1/zh unknown
- 2018-07-13 HK HK18109115.1A patent/HK1249514A1/zh unknown
-
2019
- 2019-09-25 US US16/582,468 patent/US10947210B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| HK1249514A1 (zh) | 2018-11-02 |
| MX2017012238A (es) | 2018-02-15 |
| IL254243B (en) | 2020-10-29 |
| CN107567442A (zh) | 2018-01-09 |
| CA2979555C (en) | 2023-12-19 |
| EP3274340A1 (en) | 2018-01-31 |
| KR20170137113A (ko) | 2017-12-12 |
| US10947210B2 (en) | 2021-03-16 |
| US20180050998A1 (en) | 2018-02-22 |
| US10464914B2 (en) | 2019-11-05 |
| JP2018512453A (ja) | 2018-05-17 |
| CN107567442B (zh) | 2021-05-25 |
| EA201792094A1 (ru) | 2018-03-30 |
| TWI731854B (zh) | 2021-07-01 |
| AU2016235246A1 (en) | 2017-09-21 |
| EP3274340B1 (en) | 2019-07-17 |
| SG11201707527YA (en) | 2017-10-30 |
| IL254243A0 (en) | 2017-10-31 |
| AU2016235246B2 (en) | 2020-12-10 |
| EA033622B1 (ru) | 2019-11-11 |
| HK1243703A1 (zh) | 2018-07-20 |
| DK3274340T3 (da) | 2019-10-07 |
| PH12017501687A1 (en) | 2018-03-19 |
| CA2979555A1 (en) | 2016-09-29 |
| JP6741747B2 (ja) | 2020-08-19 |
| US20200255393A1 (en) | 2020-08-13 |
| ES2748974T3 (es) | 2020-03-18 |
| NZ735093A (en) | 2022-09-30 |
| TW201643147A (zh) | 2016-12-16 |
| BR112017020168A2 (pt) | 2018-06-05 |
| WO2016154241A1 (en) | 2016-09-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL280459A (en) | Phosphoramidates for the treatment of hepatitis B virus | |
| HK1255502A1 (zh) | B型肝炎病毒(hbv)irna組合物及其使用方法 | |
| IL251450A0 (en) | Preparations and methods for silencing hepatitis b virus gene expression | |
| HK1243463A1 (zh) | 檢測rna病毒的組合物和方法 | |
| HK1244913A1 (zh) | 檢測基因組編輯 | |
| HK1248278A1 (zh) | 用於使乙型肝炎病毒基因表達沉默的組合物及方法 | |
| SG11201707663SA (en) | Lyophilization of rna | |
| IL249660B (en) | Methods for treating hepatitis b virus and hepatitis d virus infections | |
| SG10201913958QA (en) | Modulation of hepatitis b virus replication | |
| HK1249046A1 (zh) | 治療b型肝炎病毒的方法 | |
| IL248318A0 (en) | Selective inhibitors that have an effect on the hepatitis virus type c | |
| HK1249514A1 (zh) | C型肝炎病毒聚合酶的抑制劑 | |
| PL3137078T3 (pl) | Leczenie zakażenia wirusem zapalenia wątroby typu delta | |
| GB201402169D0 (en) | Viral inhibitors | |
| HK1231403A1 (zh) | 抑制β 表達的核酸 | |
| HK1245775A1 (zh) | 作為丙型肝炎病毒抑制劑的鹽 | |
| EP3445367A4 (en) | INHIBITORS OF HEPATITIS C VIRUS | |
| TH1601001227A (th) | ตัวยับยั้ง hcv โพลีเมอเรส | |
| GB201416054D0 (en) | Chemotherapy of viruses | |
| GB201403369D0 (en) | RNA Virus induced gene expression |